CYTORI THE(NSDQ:CYTX)
|
Cytori Therapeutics, Inc. is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Company''s preclinical investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem and regenerative cells, Cytori has developed its proprietary Celution System to isolate and concentrate a patient''s own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients.
|
# Employees: 143
|
|
Address: 3020 Callan Road,San Diego,CA,USA
|
|
Phone: 858 458-0900
|
Fax: 858 458-0994
|
|
Website: www.cytoritx.com
|
Email: tbaker@cytoritx.com
|
Sector: Medical
|
Industry: MED-BIOMED/GENE
|
Executive Officers
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
|
Last Earnings Date: 6/30/2008
|
|
Next Earnings Date(Expected): 11/17/2008
|
|
Mean EPS (Next Qtr): ($0.25)
|
|
Mean EPS (Year): ($1.07)
|
|
Mean Estimate(Long Term): ($0.01)
|
|
P/E Ratio(Based on EPS estimate): -0.010
|
|
Number of Estimates: 3
|
|
Shares Performance
|
Period
|
CYTX
|
Compare to S&P
|
| YTD |
10.74 %
|
29.56 %
|
| 4 Weeks |
-2.90 %
|
-4.31 %
|
| 12 Weeks |
6.01 %
|
14.08 %
|
Shares Information
|
Analyst Coverage: Y
|
Avg Volume: 113120
|
|
Shares Outstanding: 26M
|
Market Cap: $0.17B
|
| 52 Week High: $8.56
|
52 Week Low: $4.75
|
| P/E Ratio: -0.010
|
PEG Ratio: -0.010
|
|
Split: On 1/1/1990 CYTX split by factor of 0.030
|
Earnings Performance
EPS Growth in Last Quarter: 2.94 %
EPS Growth in Last Year: -94.12 %
Sales Growth in Last Quarter: 817.65 %
Sales Growth in Last Quarter: 174.22 %
Financials
|
Qtr Book Value: ($0.01)
|
|
Cash Flow/Share: ($0.01)
|
|
Change in Payout Ratio: -0.010
|
|
Price/Sales: 112.330
|
|
